NFE2L2 and cancer: Furthermore, epigenetic reprograming of NRF2 can lead to its reactivation and subsequent induction of downstream target genes involved in cellular protection (Figure 2E), further suggesting the use of KEAP1 within the NRF2 pathway as a potential target for cancer treatment.